Title:
ＩＬ−２１結合タンパク質及びその使用
Document Type and Number:
Japanese Patent JP6563389
Kind Code:
B2
Abstract:
The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-21 (IL-21) and uses thereof, e.g., in therapy.
More Like This:
| WO/2005/035572 | ANTIBODY COMPOSITIONS AND METHODS |
| WO/2023/237690 | METHODS FOR PURIFICATION OF MULTI-SPECIFIC ANTIBODIES |
| WO/2012/125680 | METHODS OF TREATING VASCULITIS USING AN IL-17 BINDING MOLECULE |
Inventors:
Mackay Charles Ray
Youdy
Youdy
Application Number:
JP2016522133A
Publication Date:
August 21, 2019
Filing Date:
June 27, 2014
Export Citation:
Assignee:
MONASH UNIVERSITY
International Classes:
C07K16/24; A61K38/20; A61K39/395; A61K45/00; A61P31/00; A61P35/00; A61P37/06; C07K14/54; C07K16/46; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12P21/08
Domestic Patent References:
| JP2013081461A | ||||
| JP2011506422A | ||||
| JP2008501042A |
Foreign References:
| WO2009100035A1 | ||||
| WO2006105538A1 |
Other References:
Gershoni, JM., et al.,Epitope mapping: The first step in developing epitope-based vaccines.,Drug development,2007年,Vol.21, No.3,p.145-156.
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office